Lori-Ann Fisher JamaicaUniversity of the West Indies, Mona

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? SK100 ChairpersonFatiu Abiola Arogundade NigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria ChairpersonFernanda Sales Luiz Vianna fslvianna@gmail.comBrazilUniversidade Federal do Rio Grande do Sul ChairpersonOpeyemi Olabisi opeyemi.olabisi@duke.eduUnited StatesDuke University School of Medicine Ethical Aspects of Race-based Genetic Testing SpeakerAna Iltis iltisas@wfu.eduUnited StatesWake Forest University Contribution of ApoL1 Risk Genotype to HIVAN SpeakerSaraladevi Naicker South AfricaUniversity of the Witwatersrand Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa SpeakerDwomoa Adu dwoms@blueyonder.co.ukGhanaUniversity of Ghana Medical School Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials SpeakerOgo Egbuna ogo_egbuna@vrtx.comUnited StatesVertex Pharmaceuticals Inc Q and A Hall C2
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 ChairpersonAgnes Fogo United States ChairpersonGuillermo Rosa Diez guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story SpeakerVictoria Gray vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture SpeakerObiageli Eunice Nnodu oennodu@gmail.comNigeriaUniversity of Abuja Hall A
4:30 p.m. 5:30 p.m.	Policy and Advocacy Approaches BKH02 ChairpersonLori-Ann Fisher JamaicaUniversity of the West Indies, Mona ChairpersonMarcello Tonelli CanadaUniversity of Calgary Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health SpeakerVivekanand Jha IndiaGeorge Institute for Global Health India The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases SpeakerValerie Luyckx valerie.luyckx@uzh.chSwitzerlandUniversity of Zurich A Case for National Prevention Programs to Manage CKD SpeakerIkechi Okpechi CanadaUniversity of Alberta Q and A Hall A